Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-18 Sale |
2024-11-20 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
5,360 | $4.08 | $21,869 | 284,685 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
22,725 | $6.45 | $146,576 | 288,031 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 8:42 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
9,846 | $15.24 | $150,053 | 306,292 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-22 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
3,287 | $9.69 | $31,851 | 217,374 (Direct) |
View |
| 2023-05-22 Sale |
2023-05-24 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
6,305 | $10.12 | $63,807 | 219,327 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 6:17 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
3,573 | $11.36 | $40,586 | 151,396 (Direct) |
View |
| 2022-11-21 Sale |
2022-11-23 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
3,335 | $11.56 | $38,553 | 154,213 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-08 Exercise |
2024-03-12 4:05 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
37,120 | $0 | 310,756 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 8:42 pm |
N/A 2027-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
97,968 | $0 | 306,292 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 5:07 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
111,354 | $0 | 262,750 (Direct) |
View |
Ownership |
2022-06-08 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
0 | $0 | 156,516 (Direct) |
View |